According to the WHO recommendations, which patients with hepatitis B (HBV) (Hep B) require lifelong nucleos(t)ide analog (NA) therapy?

Updated: Jun 08, 2021
  • Author: Nikolaos T Pyrsopoulos, MD, PhD, MBA, FACP, AGAF; Chief Editor: BS Anand, MD  more...
  • Print

All individuals with cirrhosis based on clinical evidence (or APRI score >2 in adults) require lifelong NA therapy. Antiviral therapy in these individuals should not be discontinued owing to the potential for HBV reactivation.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!